An updated patent review of metallo-β-lactamase inhibitors (2020–2023)

References

• Liu B, Trout REL, Chu GH, et al. Discovery of taniborbactam (VNRX-5133): a broad-spectrum serine- and metallo-β-lactamase inhibitor for carbapenem-resistant bacterial infections. J Med Chem. 2020;63:2789–2801 doi: 10.1021/acs.jmedchem.9b01518
   PubMed Web of Science ®Google Scholar
• Hamrick JC, Docquier JD, Uehara T, et al. VNRX-5133 (taniborbactam), a broad-spectrum inhibitor of serine- and metallo-β-lactamases, restores activity of cefepime in Enterobacterales and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2020;64(3):e01963–19. doi: 10.1128/AAC.01963-19
   PubMed Web of Science ®Google Scholar
• Hecker SJ, Reddy KR, Lomovskaya O, et al. Discovery of cyclic boronic acid QPX7728, an ultrabroad-spectrum inhibitor of serine and metallo-β-lactamases. J Med Chem. 2020;63(14):7491–7507. doi: 10.1021/acs.jmedchem.9b01976
   PubMed Web of Science ®Google Scholar
• Lomovskaya O, Tsivkovski R, Sun D, et al. QPX7728, an ultra-broad-spectrum β-lactamase inhibitor for intravenous and oral therapy: overview of biochemical and microbiological characteristics. Front Microbiol. 2021;12:697180. doi: 10.3389/fmicb.2021.697180
   PubMed Web of Science ®Google Scholar
• Mojica MF, Rossi MA, Vila AJ, et al. The urgent need for metallo-β-lactamase inhibitors: an unattended global threat. Lancet Infect Dis. 2022;22(1):e28–e34. doi: 10.1016/S1473-3099(20)30868-9
   PubMed Web of Science ®Google Scholar
• Davies DT, Leiris S, Sprynski N, et al. ANT2681: SAR studies leading to the identification of a metallo-β-lactamase inhibitor with potential for clinical use in combination with meropenem for the treatment of infections caused by NDM-producing Enterobacteriaceae. ACS Infect Dis. 2020;6(9):2419–2430. doi: 10.1021/acsinfecdis.0c00207
   PubMed Web of Science ®Google Scholar
• Bush K, Macielag MJ. New β-lactam antibiotics and β-lactamase inhibitors. Expert Opin Ther Pat. 2010;20(10):1277–1293. doi: 10.1517/13543776.2010.515588
   PubMed Web of Science ®Google Scholar
• Xie H, Zhang H, Zhang S, et al. Analysis of antibiotic patents issued in China from 1992 to 2011. Expert Opin Ther Pat. 2012;22(10):1205–1232. doi: 10.1517/13543776.2012.722204
   PubMed Web of Science ®Google Scholar
• Buynak JD. β-lactamase inhibitors: a review of the patent literature (2010-2013). Expert Opin Ther Pat. 2013;23:1469–1481. doi: 10.1517/13543776.2013.831071
   PubMed Web of Science ®Google Scholar
• Reddy N, Shungube M, Arvidsson PI, et al. A 2018-2019 patent review of metallo-β-lactamase inhibitors. Expert Opin Ther Pat. 2020;30:541–555. doi: 10.1080/13543776.2020.1767070
   PubMed Web of Science ®Google Scholar
• Hernandez J-F, Gavara L, Docquier J-D, et al. Centre National de la Recherche Scientifique; Université de Sienne; Ecole Nationale Superieure de Chimie de Montpellier; Université de Montpellier. Preparation of substituted 4,5-dihydro-1H-1,2,4-triazole thiones as inhibitors of metallo-β-lactamases for the treatment of bacterial infections. (2020) EP3653611.
   Google Scholar
• Hernandez J-F, Gavara L, Docquier J-D, et al. Centre National de la Recherche Scientifique; Université de Sienne; Ecole Nationale Superieure de Chimie de Montpellier; Université de Montpellier. Preparation of substituted 4,5-dihydro-1H-1,2,4-triazole thiones as inhibitors of metallo-β-lactamases for the treatment of bacterial infections. (2020) WO2020099645.
   Google Scholar
• Sevaille L, Gavara L, Bebrone C, et al. 1,2,4-triazole-3-thione compounds as inhibitors of dizinc metallo-β-lactamases. ChemMedchem. 2017;12(12):972–985. doi: 10.1002/cmdc.201700186
   PubMed Web of Science ®Google Scholar
• Gavara L, Sevaille L, De Luca F, et al. 4-amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors. Eur J Med Chem. 2020;208:112720. doi: 10.1016/j.ejmech.2020.112720
   PubMed Web of Science ®Google Scholar
• Legru A, Verdirosa F, Hernandez JF, et al. 1,2,4-triazole-3-thione compounds with a 4-ethyl alkyl/aryl sulfide substituent are broad-spectrum metallo-β-lactamase inhibitors with re-sensitization activity. Eur J Med Chem. 2021;(226):113873. doi: 10.1016/j.ejmech.2021.113873
   PubMedGoogle Scholar
• Gavara L, Verdirosa F, Sevaille L, et al. 1,2,4-triazole-3-thione analogues with an arylakyl group at position 4 as metallo-β-lactamase inhibitors. Bioorg Med Chem. 2022;(72):116964. doi: 10.1016/j.bmc.2022.116964
   PubMedGoogle Scholar
• Gavara L, Verdirosa F, Legru A, et al. 4-(N-alkyl- and -acyl-amino)-1,2,4-triazole-3-thione analogs as metallo-β-lactamase inhibitors: impact of 4-linker on potency and spectrum of inhibition. Biomolecules. 2020;10:1094. doi: 10.3390/biom10081094
   PubMed Web of Science ®Google Scholar
• Gavara L, Legru A, Verdirosa F, et al. 4-alkyl-1,2,4-triazole-3-thione analogues as metallo-β-lactamase inhibitors. Bioorg Chem. 2021;113:105024. doi: 10.1016/j.bioorg.2021.105024
   PubMed Web of Science ®Google Scholar
• Verdirosa F, Gavara L, Sevaille L, et al. 1,2,4-triazole-3-thione analogues with a 2-ethylbenzoic acid at position 4 as VIM-type metallo-β-lactamase inhibitors. ChemMedchem. 2022;17(7):e202100699. doi: 10.1002/cmdc.202100699
   PubMed Web of Science ®Google Scholar
• Legru A, Verdirosa F, Vo-Hoang Y, et al. Optimization of 1,2,4-triazole-3-thiones toward broad-spectrum metallo-β-lactamase inhibitors showing potent synergistic activity on VIM- and NDM-1-producing clinical isolates. J Med Chem. 2022;65(24):16392–16419. doi: 10.1021/acs.jmedchem.2c01257
   PubMed Web of Science ®Google Scholar
• Yang L, Qian S, Wang Z, et al. Xihua University. Application of triazole compound in the preparation of metallo-β-lactamase inhibitor. (2020) CN110840897.
   Google Scholar
• Li G, Wang Z. Sichupan University. Preparation of 1-substituted-1H-imidazole-2-carboxylic acid compounds use as metal β-lactamase inhibitors for antibacterial combination therapy. (2020) CN111253317.
   Google Scholar
• Li R, Su H, Chen W, et al. Design, synthesis, and biological evaluation of new 1H-imidazole-2-carboxylic acid derivatives as metallo-β-lactamase inhibitors. Bioorg Med Chem. 2022;72:116993. doi: 10.1016/j.bmc.2022.116993
   PubMed Web of Science ®Google Scholar
• Yan YH, Li W, Chen W, et al. Structure-guided optimization of 1H-imidazole-2-carboxylic acid derivatives affording potent VIM-type metallo-β-lactamase inhibitors. Eur J Med Chem. 2022;228:113965. doi: 10.1016/j.ejmech.2021.113965
   PubMed Web of Science ®Google Scholar
• Naas T, Oueslati S, Bonnin RA, et al. Beta-lactamase database (BLDB) - structure and function. J Enzyme Inhib Med Chem. 2017;32:917–919. doi: 10.1080/14756366.2017.1344235
   PubMed Web of Science ®Google Scholar
• Wilkinson A, Cooper I, Orr D, et al. Infex Therapeutics Limited. 1-aminosulfonyl-2-carboxypyrrole derivatives as metallo-β-lactamase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of bacterial infections. (2021) WO2021099793.
   Google Scholar
• Cooper I, Orr D, Wilkinson A, et al. Infex Therapeutics Limited. Preparation of sulfamoyl-pyrrole and sulfamoyl-pyrazole compounds and their use in treating bacterial infections. (2022)GB2602096.
   Google Scholar
• Wilkinson A, Cooper I, Orr D, et al. Infex Therapeutics Limited. Preparation of pyrrole derivatives as metallo-β-lactamase inhibitors. (2022) WO2022074385.
   Google Scholar
• Ooi N, Lee VE, Chalam-Judge N, et al. Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant Enterobacterales. J Antimicrob Chemother. 2021;76(2):460–466. doi: 10.1093/jac/dkaa455
   PubMed Web of Science ®Google Scholar
• Schofield C, Brem J, Panduwawala T, et al. Oxford University Innovation Limited. 2-carboxy-indoles as inhibitors of metallo-β-lactamases and their preparation. (2022) WO2022248887.
   Google Scholar
• Brem J, Panduwawala T, Hansen JU, et al. Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors. Nat Chem. 2022;14(1):15–24. doi: 10.1038/s41557-021-00831-x
   PubMed Web of Science ®Google Scholar
• Li H, Sun H. A hydroxide lock for metallo-β-lactamases. Nat Chem. 2022;14(1):6–8. doi: 10.1038/s41557-021-00871-3
   PubMed Web of Science ®Google Scholar
• Wu S, Xia J, Zhu Z, et al. Institute of Materia Medica, Chinese Academy of Medical Sciences. Preparation of indoline compound antibacterial agent. (2023) CN115974759.
   Google Scholar
• Omura S, Sunatsuka T, Hirose T, et al. Kitasato Institute. Metallo-β-lactamase inhibitor. (2022) JP2022041072.
   Google Scholar
• Hartmann RW, Konstantinovic J, Haupenthal J, et al. Helmholtz-Zentrum fuer Infektionsforschung GmbH. N-phenyl-3-mercaptopropanamide derivatives as metallo-β-lactamase inhibitors for the treatment of bacterial infections. (2021) WO2021191219.
   Google Scholar
• Kaya C, Konstantinović J, Kany AM, et al. N-aryl mercaptopropionamides as broad-spectrum inhibitors of metallo-β-lactamases. J Med Chem. 2022;65(5):3913–3922. doi: 10.1021/acs.jmedchem.1c01755
   PubMed Web of Science ®Google Scholar
• Jiang Z, Shi L, Zhang B, et al. General Hospital of Southern Theater Command. Application of α-lipoic acid for preparation of metal β-lactamase inhibitor. (2021) CN112999220.
   Google Scholar
• Jiang Z, Shi L, Zhang B, et al. General Hospital of Southern Theater Command. Application of methimazole and derivative thereof in serving as and/or preparing metal β-lactamase inhibitor for reversing resistance of bacteria to antibiotics. (2021) CN113209090.
   Google Scholar
• Jiang Z, Zhang B, He X, et al. General Hospital of Southern Theater Command. Application of 2-(1-(mercaptomethyl)cyclopropyl)acetic acid as and/or in preparation of β-lactamase inhibitor. (2021)CN113521044.
   Google Scholar
• Shi L, He X, Zhang B, et al. General Hospital of Southern Theater Command. Application of mercapto compounds as and/or in preparing β-lactamase inhibitor. (2021) CN113425726.
   Google Scholar
• Wang L, Wang X, Ye Z, et al. Nanjing Agricultural University. Application of allicin in preparation of metallo-β-lactamase inhibitor for treatment of carbapenem-resistant bacterial infection. (2022) CN114392253.
   Google Scholar
• Wang X, Tian H, Li W, et al. Nanjing Tech University. Metallo-β-lactamase inhibitor, its preparation method and application as combination of antibiotics in inhibiting bacterial proliferation. (2020) CN111718361.
   Google Scholar
• Govender T, Naicker T, Arvidsson PI, et al. University of Kwazulu-Natal; University of Zululand. Thiaazabicyclooctene as metallo-β-lactamase inhibitors and their preparation. (2023) WO2023007325.
   Google Scholar
• Peters BK, Reddy N, Shungube M, et al. In vitro and in vivo development of a β-lactam-metallo-β-lactamase inhibitor: targeting carbapenem-resistant Enterobacterales. ACS Infect Dis. 2023;9:486–496. doi: 10.1021/acsinfecdis.2c00485
   PubMed Web of Science ®Google Scholar
• Reddy N, Girdhari L, Shungube M, et al. Neutralizing carbapenem resistance by co-administering meropenem with novel β-lactam-metallo-β-lactamase inhibitors. Antibiotics. 2023;12(4):633. doi: 10.3390/antibiotics12040633
   Google Scholar
• Sawa T, Yamaguti Y, Arakawa Y. National University Corporation Kumamoto University. Metallo-β-lactamase inhibitor. (2022) WO2022239872.
   Google Scholar
• Yannakopoulou K, Agnes M, Miriagou V, et al. National Center for Scientific Research “Demokritos”; Hellenic Pasteur Institute (HPI). Iminodiacetic acid substituted cyclodextrins as potentiators of β-lactam antibiotics for treating Gram-negative bacterial infections. (2020) EP3714904.
   Google Scholar
• Zhang L, Tian Y. South China University of Technology. Preparation of metallo-β-lactamase inhibitors or pharmaceutically acceptable salts and its application. (2022) CN114085162.
   Google Scholar
• Qin S, Zhang E, Bai M, et al. Zhengzhou University. Dipicolinic acid amine and its derivatives as metal β-lactamase inhibitors in antibacterial applications. (2021) CN113425719.
   Google Scholar
• Guo S, Yao S, Shi W, et al. Shanghai Jemincare Pharmaceutical Co., Ltd.; Jiangxi Jemincare Group Co., Ltd. Preparation method of tetracyclic heterocyclic boronic acid derivative, and application thereof as metallo-β-lactamase (MBL) and/or serine-β-lactamase (SBL) inhibitors in antibacterial agent. (2023) CN115557978.
   Google Scholar
• Zhang J, Guo S, Zhang Z, et al. Shanghai Jemincare Pharmaceutical Co., Ltd. Tricyclic boronic acid derivative, and preparation method therefor and application thereof. (2023) WO2023066292.
   Google Scholar
• Salmon L, Salzburg S, Labruere R, et al. Université Paris-Saclay; Centre National de la Recherche Scientifique (CNRS); Assistance Publique - Hopitaux de Paris (AP-HP). Novel dipeptide compounds, method for the production thereof and a novel therapeutic use of dipeptide compounds. (2021) FR3111544.
   Google Scholar
• Salmon L, Salzburg S, Labruere R, et al. Université Paris-Saclay; Centre National de la Recherche Scientifique (CNRS); Assistance Publique - Hopitaux de Paris (AP-HP). Novel dipeptide compounds, method for the production thereof and a novel therapeutic use of dipeptide compounds (2021) WO2021255156.
   Google Scholar
• Zhou Y, Zhang S, Wang J, et al. Jilin University. Application of tormentic acid in preparation of carbapenemase inhibitor. (2021) CN113384587.
   Google Scholar